drugset / Trial / NCT00256399

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

NCT00256399

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.

Timeline

Start
2005-11
Primary completion
2007-05-08
Completion
2007-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule 10 mg